Results 141 to 150 of about 134,759 (289)

Antidiabetic herbal drugs: a review

Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia resulting from impaired insulin secretion, insulin action, or both.
Sarikareddy
core   +3 more sources

The association of ADHD and ADHD medication with adherence to pharmacotherapy for type 2 diabetes: a population-based cohort study from seven countries. [PDF]

EClinicalMedicine
Zhou Y, Yao H, Xie T, Gillies MB, Zhang-James Y, Brikell I, Engeland A, Gao L, Semark BD, Wimberley T, Astrup A, Dong Z, Sarsembayeva D, Vos M, Yuen ASC, Dalsgaard S, Faraone SV, Klungsøyr K, Larsson H, Man KKC, Wong ICK, Zoega H, Snieder H, Chang Z, Hartman CA.   +24 more
europepmc   +1 more source

Metrnl: A Novel Therapeutic Target in Atherosclerosis

iNew Medicine, EarlyView.
ABSTRACT Atherosclerosis is a chronic inflammatory vascular disease and the main pathological basis of cardiovascular and cerebrovascular events. Exploration of endogenous protective factors in the disease is beneficial for the establishment of new therapeutic strategies.
Pin Wang, Dao‐Xin Wang, Chao‐Yu Miao
wiley   +1 more source

γδ T-cell interferon-γ production reflects metabolic improvement during SGLT2 inhibitor-based therapy in type 2 diabetes. [PDF]

Front Endocrinol (Lausanne)
Troskot Cuculić M, Sergo D, Kavazović I, Peršić V, Wensveen FM, Turk Wensveen T.   +5 more
europepmc   +1 more source

Research Progress of Berberine in Kidney Disease: Targeting Mitochondria and Ferroptosis

iNew Medicine, EarlyView.
This figure illustrates the model‐specific renoprotective mechanisms of berberine (BBR) across three major kidney diseases. From left to right, the diagram shows that BBR targets distinct core pathways depending on the pathological context: in diabetic nephropathy (DN), BBR activates AMPK to improve mitochondrial energy metabolism; in acute kidney ...
Liuqing Wang, Rongyu Guo, Xiaojun Feng, Liqin Tang   +3 more
wiley   +1 more source

Association Between Type of Antidiabetic Treatment and Glycemic Control in Patients With Type 2 Diabetes Mellitus: A Retrospective Cross-Sectional Study. [PDF]

Cureus
Violante-Ortiz R, Narvaez Gallifa E, Hernandez Molina EE, Fernández-Ordóñez N, Guerra Cardenas JE, Reyna-Beltrán E.   +5 more
europepmc   +1 more source

Oral Antidiabetic Agents [PDF]

BMJ, 1959
openaire   +2 more sources

Protective Effects of Imeglimin Against Oxaliplatin‐Induced Peripheral Neurotoxicity: Evidence From In Vitro and In Vivo Studies

Journal of Applied Toxicology, EarlyView.
ABSTRACT Oxaliplatin is a platinum‐based anticancer agent widely used for gastrointestinal malignancies; however, it is known to cause dose‐dependent peripheral neuropathy (OIPN), a characteristic adverse effect. OIPN results in a reduced quality of life and often necessitates dose reduction or discontinuation of oxaliplatin; however, effective ...
Yusuke Koura, Kano Kinjo, Keisuke Mine, Yusuke Mori, Mami Ueda, Risa Kaneko, Yuna Kamiya, Taiga Sonoda, Haruka Mimata, Shunsuke Fujita, Takehiro Kawashiri, Daisuke Kobayashi   +11 more
wiley   +1 more source

Glycated hemoglobin (A1c) values and antidiabetic treatment deprescription in hospitalized nonagenarians with type 2 diabetes. [PDF]

Front Public Health
Morros-González E, Triviño-Beleño PA, Villamizar ES, Torres-Arias N, Marriaga-Ángel Á.   +4 more
europepmc   +1 more source

The Neutrophil‐To‐Lymphocyte Ratio as an Associated Biomarker of Diabetic Nephropathy in Type 2 Diabetes Mellitus

Journal of Clinical Laboratory Analysis, EarlyView.
Type 2 diabetes mellitus (T2DM) is associated with chronic low‐grade systemic inflammation. This study evaluated the neutrophil‐to‐lymphocyte ratio (NLR) as a practical inflammatory biomarker in T2DM. A cross‐sectional study was conducted in Hodeidah City among 82 participants: 42 T2DM patients and 40 healthy controls.
Yousef A. D. Alkhadem, Abdulmajeed A. A. Almaleki, Ali S. G. Alghamdi, Mohammed S. Al‐Ghamdi, Mohammed H. Mukhtar, Ali B. Al‐Zubaidy, Yahya Alsayaad   +6 more
wiley   +1 more source